Umary Acido Hialuronico recall
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Why was Umary Acido Hialuronico recalled?
Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots within expiry
- Product
- Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
- Recalling firm
- MAIN PRODUCTS INC
- Quantity
- 57, 340 bottles
- Distribution
- Nationwide within the U.S
- Recall date
- August 14, 2024
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)